News

The Blue Brain Nexus will help enable data-driven science through searching, integrating and tracking large-scale data and models.

Using whole-genome analysis and chemogenomics, scientists have discovered novel antimalarial drug targets and drug-resistance genes. The researchers analyzed >250 Plasmodium falciparum cell lines, which were resistant to 37 different anti-malarial compounds.

Researchers around the globe have worked together to create a DNA database of rhinoceros that will be used to help with the criminal prosecution of poachers.

A new case study has been published by Autoscribe Informatics which describes how the newly established Biobank is using the Matrix Gemini Laboratory Information Management System (LIMS) for complete tracking of all of its samples.

Johns Hopkins scientists have used a form of artificial intelligence to create a map that compares types of cellular receptors, the chemical "antennas" on the surface of immune system T-cells. Their experiments with lab-grown mouse and human T-cells suggest that people with cancer who have a greater variety of such receptors may respond better to immunotherapy drugs and vaccines.

Inspirata®, Inc. has announced that it has acquired Toronto-based Artificial Intelligence in Medicine, Inc. (AIM). AIM has spent >30 years developing and commercializing tools that leverage Artificial Intelligence (AI) and Natural Language Processing (NLP) to extract cancer related information and data from clinical documents

The Center for Computational Oncology is developing complex computer models and analytic tools to predict how cancer will progress in a specific individual, based on their unique biological characteristics.

Complex structure of a class B GPCR bound to an analogue of its endogenous ligand ignites new excitement in GPCR research.

In particular, the test could help direct treatment for women with triple-negative breast cancer, which does not respond to traditional hormone-based treatments.

A startling discovery published today in the journal Science reveals how your past history of minor bacterial infections can add up with age to cause a severe inflammatory disease.